关注
A.G. (Onno) Holleboom, MD PhD, associate professor
A.G. (Onno) Holleboom, MD PhD, associate professor
Internist endocrinologist & vascular medicine, Amsterdam UMC, University of Amsterdam
在 amsterdamumc.nl 的电子邮件经过验证
标题
引用次数
引用次数
年份
Gut microbiota and human NAFLD: disentangling microbial signatures from metabolic disorders
J Aron-Wisnewsky, C Vigliotti, J Witjes, P Le, AG Holleboom, J Verheij, ...
Nature Reviews Gastroenterology & Hepatology 17 (5), 279-297, 2020
6832020
Genetic variant of the scavenger receptor BI in humans
M Vergeer, SJA Korporaal, R Franssen, I Meurs, R Out, GK Hovingh, ...
New England Journal of Medicine 364 (2), 136-145, 2011
3752011
The HDL hypothesis: does high-density lipoprotein protect from atherosclerosis?
M Vergeer, AG Holleboom, JJP Kastelein, JA Kuivenhoven
Journal of lipid research 51 (8), 2058-2073, 2010
3012010
Compromised LCAT function is associated with increased atherosclerosis
GK Hovingh, BA Hutten, AG Holleboom, W Petersen, P Rol, A Stalenhoef, ...
Circulation 112 (6), 879-884, 2005
2162005
TNFα induces ABCA1 through NF-κB in macrophages and in phagocytes ingesting apoptotic cells
MC Gerbod-Giannone, Y Li, A Holleboom, S Han, LC Hsu, I Tabas, ...
Proceedings of the National Academy of Sciences 103 (9), 3112-3117, 2006
1322006
Plasma levels of sphingosine-1-phosphate and apolipoprotein M in patients with monogenic disorders of HDL metabolism
R Karuna, R Park, A Othman, AG Holleboom, MM Motazacker, I Sutter, ...
Atherosclerosis 219 (2), 855-863, 2011
1222011
CCDC115 deficiency causes a disorder of Golgi homeostasis with abnormal protein glycosylation
JC Jansen, S Cirak, M Van Scherpenzeel, S Timal, J Reunert, S Rust, ...
The American Journal of Human Genetics 98 (2), 310-321, 2016
1132016
Heterozygosity for a loss-of-function mutation in GALNT2 improves plasma triglyceride clearance in man
AG Holleboom, H Karlsson, RS Lin, TM Beres, JA Sierts, DS Herman, ...
Cell metabolism 14 (6), 811-818, 2011
1102011
NAFLD and atherosclerosis: two sides of the same dysmetabolic coin?
D Stols-Gonçalves, GK Hovingh, M Nieuwdorp, AG Holleboom
Trends in Endocrinology & Metabolism 30 (12), 891-902, 2019
1062019
Anti-hyperlipidemic effect of an edible brown algae, Ecklonia stolonifera, and its constituents on poloxamer 407-induced hyperlipidemic and cholesterol-fed rats
NY Yoon, HR Kim, HY Chung, JS Choi
Archives of pharmacal research 31, 1564-1571, 2008
1052008
Donor fecal microbiota transplantation alters gut microbiota and metabolites in obese individuals with steatohepatitis
JJ Witjes, LP Smits, CT Pekmez, A Prodan, AS Meijnikman, MA Troelstra, ...
Hepatology communications 4 (11), 1578-1590, 2020
1022020
The European NAFLD Registry: a real-world longitudinal cohort study of nonalcoholic fatty liver disease
T Hardy, K Wonders, R Younes, GP Aithal, R Aller, M Allison, P Bedossa, ...
Contemporary clinical trials 98, 106175, 2020
1002020
TMEM199 deficiency is a disorder of Golgi homeostasis characterized by elevated aminotransferases, alkaline phosphatase, and cholesterol and abnormal glycosylation
JC Jansen, S Timal, M Van Scherpenzeel, H Michelakakis, D Vicogne, ...
The American Journal of Human Genetics 98 (2), 322-330, 2016
912016
Microbiome-derived ethanol in nonalcoholic fatty liver disease
AS Meijnikman, M Davids, H Herrema, O Aydin, V Tremaroli, ...
Nature medicine 28 (10), 2100-2106, 2022
882022
The value of HDL genetics
AG Holleboom, M Vergeer, GK Hovingh, JJP Kastelein, JA Kuivenhoven
Current opinion in lipidology 19 (4), 385-394, 2008
882008
Plasma levels of lecithin: cholesterol acyltransferase and risk offuture coronary artery disease in apparently healthy men and women: aprospective case-control analysis nested …
AG Holleboom, JA Kuivenhoven, M Vergeer, GK Hovingh, JN van Miert, ...
Journal of lipid research 51 (2), 416-421, 2010
862010
ABCA1 mutation carriers with low high-density lipoprotein cholesterol are characterized by a larger atherosclerotic burden
AE Bochem, DF van Wijk, AG Holleboom, R Duivenvoorden, ...
European heart journal 34 (4), 286-291, 2013
822013
The role of lipophagy in the development and treatment of non-alcoholic fatty liver disease
A Grefhorst, IP van de Peppel, LE Larsen, JW Jonker, AG Holleboom
Frontiers in endocrinology 11, 601627, 2021
772021
Cholesterol acyltransferase gene mutations have accelerated atherogenesis as assessed by carotid 3.0-T magnetic resonance imaging: carriers of lecithin
R Duivenvoorden, AG Holleboom, B van den Bogaard, AJ Nederveen, ...
Journal of the American College of Cardiology 58 (24), 2481-2487, 2011
772011
Plasma levels of 27-hydroxycholesterol in humans and mice with monogenic disturbances of high density lipoprotein metabolism
R Karuna, AG Holleboom, MM Motazacker, JA Kuivenhoven, ...
Atherosclerosis 214 (2), 448-455, 2011
692011
系统目前无法执行此操作,请稍后再试。
文章 1–20